Experience Leucine AI.
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

Sub System
Environmental Monitoring

Environmental Monitoring

View Detailed Analysis

Analytics Overview

146
Form 483s Issued
19
483s converted to WL
291
Total Observation
Form 483s Issued
+74 from last period

Analytics Overview

Form 483 Conversion Rate by Year
Form 483s Issued (Yearly)

Recent Form 483s & Warning Letters

View all 483’s
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
19 Nov 2024
Dr. Reddy's Laboratories Limited (Unit II)
Drugs
25 Oct 2024
OSRX Inc.
Drugs
27 Sep 2024
Brookfield Medical Surgical Supply, Inc.
Drugs
27 Sep 2024
RC Outsourcing, LLC
Drugs
25 Sep 2024
Nephron Sterile Compounding Center LLC
Drugs

Top Investigators

Investigator Name
Form 483 Count
Warning Letter Count
Justin A Boyd
35
7
Anastasia M Shields
24
5
Camerson E Moore
16
0
Jazmine N Brown
15
0
Edmund F Mrak
12
4
TITLE/ COMPANY Issue Date Status Details
Buildings used in the manufacturing of Intermediates and finished APIs are not maintained in a good state of repair.
Dr. Reddy's Laboratories Limited (Unit II)
19 Nov 2024 Normal Justification: The presence of flying insects indicates a breach in environmental controls affecting product safety.
Excerpt: I observed presence of flying insects during my inspectional walkthrough of (b) Block.
View Details
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions
OSRX Inc.
25 Oct 2024 Normal Justification: The observation directly cites deficiencies in environmental monitoring practices of aseptic processing areas, requiring revised protocols.
Excerpt: Specifically, A) There are no ISO 5 viable surface samples taken during the earlier lots being manufactured.
View Details
Your firm failed to appropriately clean equipment located in the ISO 5 area.
Brookfield Medical Surgical Supply, Inc.
27 Sep 2024 Normal Justification: Link to Environmental Monitoring due to the failure in acting on excursion data.
Excerpt: Your firm failed to perform a (b) (4) clean when environmental monitoring excursions involve objectionable organisms...
View Details
Laboratory records do not include the initials or signature of a second person showing that the original records have been reviewed for accuracy, completeness and compliance with established standards.
RC Outsourcing, LLC
27 Sep 2024 Normal Justification: The effectiveness of environmental monitoring is dependent on accurate and verified data to ensure contamination control.
Excerpt: Results are recorded in an Excel sheet. However, the raw EM data can be altered in the Excel sheet.
View Details
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written and followed.
RC Outsourcing, LLC
27 Sep 2024 Normal Justification: Adequate environmental monitoring is necessary for maintaining aseptic conditions, as deficiencies were noted in gowns and non-viable monitoring.
Excerpt: The EM monitoring of non-viable particles and active air sampling are inadequate.
View Details

Prepare Better for FDA Audits with FDA Tracker

Get Real-time Insights: FDA 483s & Warning letters.
Uncover Trends: FDA Investigator profiles & Observations.
Stay Compliant: Manage risks proactively.